None listed
Conditions
Interventions
Drug : During ronbot assited laparoscopic prostatectomy, after urethral anastomosis, normal sailine 1 ml or Ketorolac (30 mg) 1 ml will be injected by group.
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1) Male Patients Undergoing Robot Assisted Laparoscopic Prostatectomy 2) 20 years = age < 80 years 3) Patients who voluntarily agreed to this clinical study 4) American society of anesthesia (ASA) classification 1 - 2
Exclusion criteria
Exclusion criteria: 1) Change to surgical plan to open surgery 2) Overactive bladder, neurogenic bladder, baldder outflow obstruction 3) Morbid obesity 4) Uncontrolled hypertension, heart failure; ejection fraction 1.6 mg/dL or dilaysis, risk of renal failure because of hypovolemia or dehydration 6) Intracranial hemorrhage or history 7) Gastroinestinal ulcer, perforation, hemorrhage or history 8) Coagulopathy, bleeding diasthesis, wafarin, heparin administration 9) Administration of probenecid, Litum, pentoxifylline, diuretics 10) Asministration of other NSAID 11) History of allergy, anaphylaxis, other side effects to NSAID 12) History of asthma, nasal polyp, angioedema, bronchospasm 13) Chronic analgesics medication 14) Psychiatric disorder 15) Refusal of patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidece of catheter related bladder discomfort (CRBD) | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidece of catheter related bladder discomfort (CRBD);Incidece of catheter related bladder discomfort (CRBD);Incidece of catheter related bladder discomfort (CRBD);Numeric rating scale (NRS);Numeric rating scale (NRS);Numeric rating scale (NRS);Numeric rating scale (NRS);Analgesic dose during posoperative 24 hrs;Posoperative complications;Postoperative nasea and vomiting;Global perceived effect scale (GPES) | — |
Countries
Korea, Republic of
Contacts
Public ContactJun-Young Park
Asan Medical Center
Outcome results
None listed